FDA Investigator Muna Algharibeh
Muna Algharibeh has inspections in 3 countries as of 12 Oct 2023. Muna Algharibeh has collaborated with a combined 2949 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
12 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Mexico,
India
Co-Investigator(s):
Alicia M Mozzachio,
Amir Alavi,
Ana P Pineda Zavaleta,
Andrace Lde Yampert,
Andrea D Swingle,
Anna M Brannen,
Ava M Bowman,
Bei Y He,
Benjamin J Smith,
Brian D Nicholson,
Bruce H Mccullough,
Byungja E Marciante,
Calvin K Cook,
Carl A Huffman, III,
Charles I Ann,
Charles L Zhou,
Charles M Spyr,
Cherrie A Zachary,
Christopher D Leach,
Christopher T Middendorf,
Claudia Mperez Kasmarski,
Constantin Y Philopoulos,
Corrine M Carter,
Courtney E Hillier,
Cristina Ausin Moreno, PhD,
Cristina Ausin Moreoo, PhD,
Cynthia Jim, CSO,
Daniel J Gorski,
David A Paterson,
Debara R Reese,
Debara Reese,
Debra I Love,
Denise L Burosh,
Dennis Cantellops Paite,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dina A Tallman,
Donald C Obenhuber, PhD,
Dr. Robert C Horan, MD,
Eboni S Funderburk,
Edwin Jao,
Elizabeth L Loreaux,
Elizabeth Ll Edwards,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Esther C Broner, PhD,
Gary Durbiel Goldner,
German Rivera,
Herberto Negron Rivera,
Heriberto Negron Rivera,
Hyung Yul Lee,
James A Lane,
James W Plucinski,
Jean Blackston Hill,
Jean Blackstone Hill,
Jeffrey A Sommers,
Jeffrey D Meng,
Jeffrey P Raimondi,
Jennifer A Kemp,
Jon P Antoniou,
Jose Acruz Gonzalez,
Joseph A Piechocki,
Joseph R Strelnik,
Joshua P Wireman,
Joslyn K Brunelle, PhD,
Justin A Boyd,
Karen M Montgomery (KMM),
Kathleen R Jones, PhD,
Kham Phommachanh,
L'oreal F Walker,
Larry K Austin,
Lauren Iacono Connors, PhD,
Lauren N Howard,
Lauren N Smith,
Laurimer Kuilan Torres,
LCDR Sean Byrd,
Leigh Anne Myers,
Lewis K Antwi,
Lianji Jin,
Lindsey M Schwierjohann,
Lisa M Bellows,
Logan T Williams,
Luella J Rossi,
Maria Cruz Fisher,
Maria G Gutierrez Hoffman,
Maria Gutierrez Hoffman, PhD,
Maria I Cruz Fisher,
Matt D Suedkamp,
Meisha R Sampson,
Meisha Waters,
Melina Rodriguez Upton,
Mercy Oyugi,
Merry Christie, PhD,
Michael L Casner,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Michele Perry Williams,
Montgomery Montgomery, Karen M,
Muna Alghribeh,
Myra K Casey,
Nailing Zhang,
Neal D Singletary, PhD,
Neali H Lucas,
Nibin Varghese, MS,
Nicholas L Paulin,
Norman K Starks,
Patricia A Cochran,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Philip F Istafanos, DMV, MS,
Qiao Y Bobo,
Rabia Ballica, PhD,
Rafael Nevarez Nieves,
Rafeeq A Habeeb,
Ramesh Potla, PhD,
Raymond T Oji,
Reba A Gates,
Rebecca E Dombrowski,
Richard T Riggie,
Riley C Myers, PhD,
Robert Barbosa,
Robert D Tollefsen,
Robert J Ham,
Robert M Barbosa,
Rong Wang, PhD,
Russell K Riley,
Sandra A Boyd,
Sangeeta M Khurana, PhD,
Sara M Onyango,
Sargum C Sood,
Scott R Nichols, PhD,
Sean R Bryd,
Sneha S Patel,
Steven Fong, MS, PhD,
Steven P Eastham,
Susan F Laska, MS,
Susan P Bruederle,
Suyang Qin,
Teresa K Kastner,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Tina M Pawlowski,
Tracey L Harris,
Tracy Denison, PhD,
Vaishali J Patel,
Wayne D Mcgrath,
Wayne E Seifert,
Wendy G Tan, PhD,
William D Tingley,
Yangmin Ning,
Yanming An, PhD,
Yumi J Hiramine
Muna Algharibeh's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2023 | FDA 483 | PANACEA BIOTEC PHARMA LIMITED - Form 483, 2023-10-12 |
February, 2022 | FDA 483 | COOK BIOTECH INCORPORATED - Form 483, 2022-02-11 |
September, 2022 | FDA 483 | Catalent Indiana, LLC - Form 483, 2022-09-01 |
March, 2021 | FDA 483 Response | Eli Lilly and Company - Form 483R, 2021-04-06 |
June, 2021 | EIR | Sentry BioPharma Services - EIR, 2021-06-29 |
March, 2021 | FDA 483 | Eli Lilly and Company - Form 483, 2021-03-16 |
September, 2022 | EIR | Catalent Indiana, LLC - EIR, 2022-09-01 |
April, 2022 | FDA 483 | Accugen Laboratories, Inc. - Form 483, 2022-04-22 |
March, 2022 | FDA 483 | MD Logistics, LLC - Form 483, 2022-03-04 |
August, 2021 | FDA 483 | Ceela Naturals - Form 483, 2021-08-31 |
May, 2022 | FDA 483 | Resilience US, Inc. - Form 483, 2022-05-25 |
May, 2022 | FDA 483 | Resilience US, Inc. - Form 483, 2022-05-25 |
December, 2023 | FDA 483 | Exelead, Inc. - Form 483, 2023-12-20 |
November, 2022 | FDA 483 | Kashiv BioSciences, LLC - Form 483, 2022-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more